Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Respiratory Impairment in Mucopolysaccharidosis Patients: Impact of Glycosaminoglycans (GAG) on the Proteases/Antiproteases Balance

NCT04112602 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT04112602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04112602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Respiratory Impairment in Mucopolysaccharidosis Patients: Impact of Glycosaminoglycans (GAG) on the Proteases/Antiproteases Balance
Lead sponsor
University Hospital, Tours
Phase
Observational
Overall status
Completed
Start date
November 12, 2019
Completion date
June 26, 2020
Enrollment
27 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

mucopolysaccharidoses